High Atherogenic Risk in Ketosis-Prone Type 2 Diabetic Individuals with Ketosis Episodes: A Cross-Sectional Study

References

• Namitha D, Nusrath A, Asha Rani N, et al. Role of lipid indices in the assessment of microvascular risk in type 2 diabetic retinopathy patients. Cureus. 2022;14(3):e23395. doi:10.7759/cureus.23395
   PubMed Web of Science ®Google Scholar
• Du S, Zhang H, Wu H, Ye S, Li W, Su Q. Prevalence and Gender Differences of Metabolic Syndrome in Young Ketosis-Prone Type 2 Diabetic Individuals: a Retrospective Study. Diabetes Metab Syndr Obes. 2020;13:2719–2727. doi:10.2147/DMSO.S252492
   PubMed Web of Science ®Google Scholar
• He X, Luo Y, Hao J, et al. Association between serum vitamin D levels and ketosis episodes in hospitalized patients with newly diagnosed ketosis-prone type 2 diabetes. Diabetes Metab Syndr Obes. 2022;15:3821–3829. doi:10.2147/DMSO.S389609
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Cui W, et al. The clinical and metabolic characteristics of young-onset ketosis-prone type 2 diabetes in China. Endocr Pract. 2015;21(12):1364–1371. doi:10.4158/EP15778.OR
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhu J, Lai X. Development and validation of a risk prediction model for ketosis-prone type 2 diabetes mellitus among patients newly diagnosed with type 2 diabetes mellitus in China. Diabetes Metab Syndr Obes. 2023;16:2491–2502. doi:10.2147/dmso.S424267
   PubMed Web of Science ®Google Scholar
• Jain SK, McVie R, Jackson R, Levine SN, Lim G. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care. 1999;22(7):1171–1175. doi:10.2337/diacare.22.7.1171
   PubMed Web of Science ®Google Scholar
• Gebreyesus HA, Abreha GF, Besherae SD, et al. High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia. PLoS One. 2022;17(2):e0262610. doi:10.1371/journal.pone.0262610
   PubMed Web of Science ®Google Scholar
• Wang JW, Wang AP, Chen MY, et al. Prevalence and clinical characteristics of hypertension and metabolic syndrome in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. Diabetol Metab Syndr. 2019;11:31. doi:10.1186/s13098-019-0426-x
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang X, Li X, Feng J, Chen X. Association of metabolic syndrome with atherogenic index of plasma in an urban Chinese population: a 15-year prospective study. Nutr Metab Cardiovasc Dis. 2019;29(11):1214–1219. doi:10.1016/j.numecd.2019.07.006
   PubMed Web of Science ®Google Scholar
• Kluck GEG, Qian AS, Sakarya EH, Quach H, Deng YD, Trigatti BL. Apolipoprotein A1 protects against necrotic core development in atherosclerotic plaques: PDZK1-dependent high-density lipoprotein suppression of necroptosis in macrophages. Arterioscler Thromb Vasc Biol. 2023;43(1):45–63. doi:10.1161/ATVBAHA.122.318062
   PubMed Web of Science ®Google Scholar
• Xu X, Song Z, Mao B, Xu G, Garcia V. Apolipoprotein A1-related proteins and reverse cholesterol transport in antiatherosclerosis therapy: recent progress and future perspectives. Cardiovasc Ther. 2022;2022:1–9. doi:10.1155/2022/4610834
   Web of Science ®Google Scholar
• Chou YC, You SL, Bai CH, Liao YC, Wei CY, Sun CA. Utility of apolipoprotein measurements in predicting incident type 2 diabetes: a Chinese cohort study. J Formos Med Assoc. 2020;119(1 Pt 1):51–58. doi:10.1016/j.jfma.2019.03.001
   PubMed Web of Science ®Google Scholar
• Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, et al. Atherogenic Index of Plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240. doi:10.1186/1476-511X-6-1
   PubMedGoogle Scholar
• Akdogan M, Ustundag-Budak Y, Huysal K. The association of hematologic inflammatory markers with atherogenic index in type 2 diabetic retinopathy patients. Clin Ophthalmol. 2016;10:1797–1801. doi:10.2147/OPTH.S110749
   PubMedGoogle Scholar
• Yi Q, Ren Z, Bai G, et al. The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese. Acta Diabetol. 2022;59(2):269–279. doi:10.1007/s00592-021-01801-y
   PubMed Web of Science ®Google Scholar
• Landowska M, Zebrowska A, Fajer K, et al. Atherosclerosis risk factors in patients with reactive hypoglycemia. Diabetes Metab Syndr Obes. 2022;15:3133–3142. doi:10.2147/DMSO.S371706
   PubMed Web of Science ®Google Scholar
• Haas AV, McDonnell ME. Pathogenesis of cardiovascular disease in diabetes. Endocrinol Metab Clin North Am. 2018;47(1):51–63. doi:10.1016/j.ecl.2017.10.010
   PubMed Web of Science ®Google Scholar
• Zhu L, Lu Z, Zhu L, et al. Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people. Kardiol Pol. 2015;73(10):931–938. doi:10.5603/KP.a2015.0086
   PubMed Web of Science ®Google Scholar
• Li LX, Zhao CC, Ren Y, et al. Prevalence and clinical characteristics of carotid atherosclerosis in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. Cardiovasc Diabetol. 2013;12:18. doi:10.1186/1475-2840-12-18
   PubMed Web of Science ®Google Scholar
• Li MF, Ren Y, Zhao CC, et al. Prevalence and clinical characteristics of lower limb atherosclerotic lesions in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. Diabetol Metab Syndr. 2014;6:71. doi:10.1186/1758-5996-6-71
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu C, Augusto Monteiro Cardoso Lopes M, et al. A cross-sectional study of atherosclerosis in newly diagnosed patients with ketosis-prone type 2 diabetes. Diabetes Metab Syndr Obes. 2022;15:933–941. doi:10.2147/DMSO.S349467
   PubMed Web of Science ®Google Scholar
• Kanikarla-Marie P, Jain SK. Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes. Free Radic Biol Med. 2016;95:268–277. doi:10.1016/j.freeradbiomed.2016.03.020
   PubMed Web of Science ®Google Scholar
• Chappey O, Wautier MP, Boval B, Wautier JL. Endothelial cells in culture: an experimental model for the study of vascular dysfunctions. Cell Biol Toxicol. 1996;12(4–6):199–205. doi:10.1007/BF00438146
   PubMed Web of Science ®Google Scholar
• Alharby H, Abdelati T, Rizk M, et al. Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes. Cardiovasc Endocrinol Metab. 2019;8(3):73–76. doi:10.1097/XCE.0000000000000175
   PubMed Web of Science ®Google Scholar
• Ito F, Sono Y, Ito T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants. 2019;8:(3) doi:10.3390/antiox8030072.
   Web of Science ®Google Scholar
• Velusamy T, Jain SK. Effects of high glucose and ketosis (acetoacetate, ss-hydroxybutyrate) on PAI-1 secretion in human umbilical vascular endothelial cells. Clin Appl Thromb Hemost. 2011;17(3):288–292. doi:10.1177/1076029610366434
   PubMed Web of Science ®Google Scholar
• Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport. Circ Res. 2019;124(10):1505–1518. doi:10.1161/circresaha.119.312617
   PubMed Web of Science ®Google Scholar
• Ben-Aicha S, Badimon L, Vilahur G. Advances in HDL: much more than lipid transporters. Int J Mol Sci. 2020;21:(3) doi:10.3390/ijms21030732.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang Y, Wang X, Dong H. Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study. BMC Endocr Disord. 2021;21(1). doi:10.1186/s12902-021-00726-5
   Web of Science ®Google Scholar
• Ye S, Ran H, Zhang H, et al. Elevated serum triglycerides are associated with ketosis-prone type 2 diabetes in young individuals. Diabetes Metab Syndr Obes. 2021;14:497–504. doi:10.2147/DMSO.S296085
   PubMed Web of Science ®Google Scholar
• Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation. 2006;114(7):681–687. doi:10.1161/CIRCULATIONAHA.106.622514
   PubMed Web of Science ®Google Scholar
• Huang Y, Hu Y, Mai W, et al. Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease. Dis Markers. 2011;31(5):295–301. doi:10.3233/DMA-2011-0832
   PubMed Web of Science ®Google Scholar
• Zhu B, Bu L, Zhang M, et al. HbA1c as a screening tool for ketosis in patients with type 2 diabetes mellitus. Sci Rep. 2016;6:39687. doi:10.1038/srep39687
   PubMed Web of Science ®Google Scholar
• Sala L PF L, Ceriello A, Ceriello A. The link between diabetes and atherosclerosis. Eur J Prev Cardiol. 2019;26(2_suppl):15–24. doi:10.1177/2047487319878373
   PubMed Web of Science ®Google Scholar
• Patricia MK, Natarajan R, Dooley AN, et al. Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells. Circ Res. 2001;88(7):659–665. doi:10.1161/hh0701.088838
   PubMed Web of Science ®Google Scholar